GevRx Nutraceuticals, Inc.

New Filing
CIK: 0002156105·Biotechnology·DELAWARE·Filed: Sep 18, 2026
Total Offering

$3,000,000

Amount Sold

$300,000

Investors

1

First Sale

Sep 11, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2026
Non-Accredited Investors
No

Related Persons

NameRole
James Thomas Christopher
Douglas Spiel, M.D.
Mary Stephen Esposito
Dylan Tyler Spiel
Michael J. Betley, Ph.D.

Company

GevRx Nutraceuticals, Inc.

20 MARBLE LOOP

STATEN ISLAND, NY, 10309

(917) 939-9424

SEC Filing

0001213900-26-101304

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free